Delaware

  • October 13, 2026

    Judge Finds Cyanide Antidote Generic Infringes IP After Trial

    A Delaware federal judge ruled Tuesday that a generic version of a cyanide antidote was infringing three patents asserted by Hope Medical Enterprises after a bench trial where Accord Healthcare Inc. claimed its product did not infringe and that the patents were invalid.

  • October 13, 2026

    Bay Point Sues Del. Fund For Books And Records

    Bay Point Capital Partners II LP has sued a Delaware investment fund and its general partner in the Delaware Chancery Court, seeking access to financial records and other documents after Bay Point acquired a limited partnership interest through a foreclosure earlier this year.

  • October 13, 2026

    CarePoint Owes 401(k) Payments Post-Ch. 11, Union Says

    A healthcare workers union has accused CarePoint Health and operators that took over two of its New Jersey hospitals of failing to make 2024 retirement fund contributions under a settlement in the defunct nonprofit's Delaware bankruptcy case.

  • October 13, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week saw stockholders challenge Nvidia Corp.'s roughly $20 billion deal with artificial intelligence chipmaker Groq Inc., Hertz Global Holdings Inc.'s electric vehicle strategy and more than $1.5 billion in Humana Inc. stock buybacks.

  • October 13, 2026

    Character.AI Files Ch. 11 With $20M Sale Bid From Disney

    Artificial intelligence entertainment platform Character Technologies has filed for Chapter 11 protection in Delaware with more than $50 million in debt, saying it was sunk by high operating and legal costs and plans an asset auction with a baseline $20 million bid from Disney.

  • October 13, 2026

    Justices Turn Away Ex-Ruby Tuesday Execs' Benefits Case

    The U.S. Supreme Court on Tuesday rejected former Ruby Tuesday executives' bid for review of their claims that Regions Bank underpaid them after their deferred compensation benefits were liquidated in bankruptcy, turning away a case the ex-executives said presented a circuit split.

  • October 09, 2026

    Real Estate Recap: Q3 Deals, NYC Renos, Calif. Data Center Laws

    Catch up on this past week's key developments by state from Law360 Real Estate Authority — including a look at the top real estate deals of the third quarter, and conversations with leading attorneys on older New York City buildings and new California data center laws.

  • October 09, 2026

    Symbotic Hid Contractor's Delays From Investors, Suit Says

    The top brass of warehouse robotics company Symbotic Inc. has been sued in Delaware Chancery Court by a shareholder who claims they hid problems with a contractor, including project delays and major cost overruns, that later forced the company to restate its financials and caused its share price to drop.

  • October 09, 2026

    Amazon Can't Push Back FTC Antitrust Trial

    A Washington federal judge refused Friday to delay the Federal Trade Commission antitrust trial accusing Amazon.com Inc. of creating an artificial pricing floor in online retail, forcing the company to try to navigate a potential timing overlap in parallel state court litigation from the California attorney general.

  • October 09, 2026

    Gene Therapy Patent Suit Against Sarepta Comes To Close

    Sarepta Therapeutics Inc. no longer has to face a lawsuit accusing it of infringing a University of Pennsylvania gene therapy patent licensed by clinical-stage biotechnology company Regenxbio Inc. after the parties told a Delaware federal judge they agreed to end the case.

  • October 09, 2026

    States Fight DOL's Ax Of Unemployment Insurance Grants

    Fourteen states sued the federal government in the U.S. Court of Federal Claims on Friday, alleging the U.S. Department of Labor wrongfully terminated grants intended for modernizing their unemployment insurance programs.

  • October 09, 2026

    'A Moral Hazard': Kalshi Drug Trial Bets Spark Ethical Qualms

    Kalshi Inc. opening prediction markets for clinical drug trials has raised a host of compliance concerns for attorneys, including the risk of insider trading among the wide swaths of stakeholders in the know about the trials, as well as the danger of compromising the trials themselves.

  • October 09, 2026

    CNN Says Azerbaijan Can't Sue Over Israel-Iran Report

    CNN has urged a Delaware federal court to throw out Azerbaijan's defamation lawsuit over the network's report that Israel used the country as a base for covert operations against Iran, arguing the First Amendment bars governments, foreign or domestic, from suing news organizations over criticism of their conduct.

  • October 09, 2026

    Amazon Wants Out Of Website Patent Suit, Citing EBay Ruling

    Amazon said Thursday it shouldn't have to face a lawsuit accusing it of infringing a pair of patents on customizing access to websites, telling a Washington federal court that not only are the patents expired, the inventions were not patent eligible in the first place.

  • October 09, 2026

    Del. Justices Back ATG In Empery Proxy Fight

    The Delaware Supreme Court has upheld a Chancery Court ruling requiring digital asset company Empery Digital Inc. to allow activist investor ATG Capital Opportunities Fund LP's nine board nominees to stand for election, rejecting the company's challenge less than a week before its annual meeting Oct. 14.

  • October 08, 2026

    Taro Pharma Says MDL Deal Bars States' Duplicative Claims

    Taro Pharmaceuticals USA asked a Connecticut federal judge to toss generic-drug price-fixing claims brought by a coalition of states on behalf of consumers that are duplicative of claims the consumers have already resolved through settlements in separate multidistrict litigation.

  • October 08, 2026

    Mayne, Ascend Cut $1M Generic Price-Fixing Deal With States

    Ascend Laboratories, Mayne Pharma and Citron Pharma asked a Connecticut federal judge Thursday to sign off on a settlement with a coalition of states resolving claims the companies were involved in an illegal conspiracy to fix prices and suppress competition for generic drugs in the United States. 

  • October 08, 2026

    Feds Say End Of Chevron Deference Justifies ESA 'Harm' Rule

    The U.S. Fish and Wildlife Service and National Marine Fisheries Service told California and South Carolina federal judges that the Trump administration's redefinition of "harm" under the Endangered Species Act was permissible after the overturning of Chevron deference.

  • October 08, 2026

    Zoox Investors, Directors Clash Over Amazon Deal Class

    The Delaware Chancery Court on Thursday took under advisement a bid to certify a class of former Zoox Inc. common stockholders challenging Amazon.com Inc.'s $1.3 billion acquisition of the autonomous vehicle company, after hearing arguments over whether releases signed by most proposed class members prevent the case from proceeding on a classwide basis.

  • October 08, 2026

    Lawmakers Push For Protections In $10M Spirit Data Sale

    More than 120 mostly Democratic lawmakers raised concerns Thursday about the proposed $10 million sale of Spirit Airlines' internal data to Google for artificial intelligence training, saying the sale would involve an "extraordinary volume" of internal records containing individuals' sensitive information.

  • October 08, 2026

    Boston Scientific Brings Heart Puncture Patent Suit

    Boston Scientific has sued Johnson & Johnson-owned medical device company Atraverse Medical Inc., claiming it infringed a patent covering a method of puncturing heart tissue.

  • October 08, 2026

    Disney, ESPN Sued Over Streaming Patents By Korean Group

    A South Korean government research institution and three universities have sued Disney, Hulu and ESPN in Delaware federal court claiming part of their ways of providing videos infringes a series of streaming patents.

  • October 08, 2026

    Nikola's Pardoned Ex-CEO Seeks To Flip Ch. 11 Claim Ruling

    The former CEO of electric-truck maker Nikola has asked the Third Circuit to review a Delaware federal judge's decision that his nearly $70 million bankruptcy claim against his former company was properly subordinated in the debtor's Chapter 11, despite a pardon from President Donald Trump.

  • October 08, 2026

    'Chicken Soup' Parent Owes $25M Judgment, Investor Says

    The entity that manages self-help book publisher Chicken Soup for the Soul Holdings LLC should be ordered to pay $25 million after a sale of most of an affiliate's assets never materialized, according to an investor seeking to recover some of its alleged $50 million in losses.

  • October 08, 2026

    Humana Brass Face Derivative Suit Alleging Illegal Kickbacks

    A Humana Inc. shareholder is suing 12 current and former company leaders in Delaware Chancery Court, alleging they allowed the health insurer to pay more than $100 million in illegal broker kickbacks, to conceal worsening medical costs and Medicare Advantage plan quality, and to waste more than $1.5 billion buying back company stock at inflated prices.

Expert Analysis

  • Series

    Juggling And Unicycling Make Me A Better Lawyer

    Author Photo

    Because I juggle (sometimes with fire) and ride the unicycle, friends and family used to joke that I should join the circus, but I pursued the practice of law instead and learned that my hobbies benefit my profession in several important ways, says Morgan Eddy at Smith Currie.

  • How 'Swap' Fight Underpins Prediction Market Enforcement

    Author Photo

    As courts around the country grapple with whether, and under what circumstances, event contracts qualify as swaps, federal enforcement authority hangs in the balance, with implications for companies that need to manage compliance risks during this period of legal uncertainty, say attorneys at Debevoise.

  • Justices' Hikma Reasoning May Extend Well Beyond Pharma

    Author Photo

    The active steps framework announced by the U.S. Supreme Court in its Hikma v. Amarin decision, finding that Amarin failed to plausibly allege inducement of infringement, has the potential to reshape how courts evaluate inducement claims across patent, copyright and other doctrines, say attorneys at BCLP.

  • SVB Parent's Claim Loss To FDIC Bears Bond Wording Lesson

    Author Photo

    A North Carolina federal court’s recent ruling that the Federal Deposit Insurance Corp., as receiver for the collapsed Silicon Valley Bank, solely owns a $73 million fraud claim illustrates why parent financial institutions should scrutinize joint assured provisions in fidelity bonds to prevent a failed subsidiary's covered losses going to a receiver, say attorneys at McGuireWoods.

  • The State Of Prediction Market Litigation After 9th Circ. Ruling

    Author Photo

    The Ninth Circuit's recent decision in Kalshi v. Assad gives state regulators significant appellate backing to enforce state gaming laws over prediction markets, creating a direct split with the Third Circuit that will likely lead to Supreme Court review of the question, say attorneys at Arnold & Porter.

  • Deal Termination Lessons From Verisk Merger Review Ruling

    Author Photo

    The Delaware Chancery Court’s recent ruling that Verisk Analytics forfeited its right to terminate a deal that was facing a second information request from the Federal Trade Commission illustrates the danger of information gaps between client and counsel and the risks of "willful conduct" language in merger agreements, say attorneys at HSF Kramer.

  • Series

    Ballet Makes Me A Better Lawyer

    Author Photo

    A lifetime of learning and performing ballet taught me that success — whether in dance or practicing law — comes only through hours of thorough preparation, boundless energy and relentless effort, says Sharon Katz-Pearlman at Greenberg Traurig.

  • Del. Dispatch: More Earnout Guidance From Chancery

    Author Photo

    The Delaware Court of Chancery's recent decision in Georgia Security Solutions v. NewCBN reaffirms that a procedure resembling a traditional accountant true-up will generally be interpreted as calling for an expert determination, not an arbitration, and highlights the need for clarity in drafting earnout provisions, say attorneys at Fried Frank.

  • How The Uniform ABC Act Reframes The Ch. 11 Choice

    Author Photo

    In states where the Uniform Assignment for Benefit of Creditors Act has been enacted — now including Delaware — qualifying distressed companies have a lower-cost, bankruptcy alternative that provides fiduciary oversight without invoking the formal Chapter 11 process, says Robert Saunders at Pachulski Stang.

  • Fed. Circ. In July: Meeting The Enablement Requirement

    Author Photo

    The Federal Circuit's decision in Wyeth v. AstraZeneca last month exemplifies when a generalized conception of an invention is insufficient to enable the full scope of asserted patent infringement claims, and may lead to more enablement challenges, say attorneys at Knobbe Martens.

  • Calif. Ruling Opens Del. Cos. Up To Stockholder Inspection

    Author Photo

    A California appellate court's recent decision in Salamon v. Orchid Global underscores that despite last year's amendments to the Delaware General Corporation Law, Delaware companies with principal operations in California remain subject to California's broader and more stockholder-protective inspection regime, say attorneys at Sheppard.

  • Series

    Taekwondo Makes Me A Better Lawyer

    Author Photo

    Taekwondo has taught me to recognize when to fight for a position and when to focus on finding a solution, and that the best outcomes are often achieved by solving problems — all of which has improved my work as a bankruptcy lawyer, mediator and Subchapter V trustee, says Amy Denton Mayer at Berger Singerman.

  • Del. Ruling Clarifies Public Benefit Corp. Fiduciary Duties

    Author Photo

    In Drakes Landing v. Tilden Park, the Delaware Court of Chancery recently provided landmark guidance for directors of Delaware public benefit corporations on the fiduciary duties they owe, highlighting that change-of-control transactions may now be protected from challenge under the state's 2025 safe harbor amendments, say attorneys at Richards Layton.

  • Del. Boeing Ruling Shows How Compliance Defeats Caremark

    Author Photo

    The Delaware Chancery Court's recent dismissal of shareholder litigation against Boeing's board in the wake of the Alaska Airlines door-plug blowout incident carries significant lessons for shareholders pursuing Caremark claims, and for corporate counsel advising boards on oversight obligations, says Brian Rostocki at Reed Smith.

  • New Fortress Ch. 15 Adds Fuel To English Restructuring Trend

    Author Photo

    After New Fortress Energy recently became the third Nasdaq-listed company to successfully undertake an English restructuring plan and gain Chapter 15 recognition, U.S. debtors should not overlook this most recent of English exports as a highly effective tool for resolving balance sheet issues, say attorneys at Faegre Drinker.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Delaware archive.